This pathway should be used for patients with SS, SC, or Sβ-thalassemia type
sickle cell disease who present with a suspected vaso-occlusive pain event
©2014 by The Children's Hospital of Philadelphia, all rights
Legal Disclaimer: These clinical pathways are based upon the opinions of staff members of The Children's Hospital of Philadelphia. Treatment should be individualized and based upon the clinical conditions of each patient.